The Effects of Peer Co-led Educational Group Intervention for Adults With Attention-Deficit Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity Clinical Trial

— ADHD  

Official title:

The Effects of Peer Co-led Educational Group Intervention for Adults With Attention-Deficit Hyperactivity/Impulsivity Disorder

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03547843
• Other study ID #: 2017/2405 REK
• Status: Completed
• Phase: N/A
• Start date: May 31, 2018
• Est. completion date: March 15, 2020

Study information

• Verified date: August 2021
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Peer co-led education describes educators who are expert patients, user representatives or former patients, participating and teaching in educational interventions in cooperation with health care professionals. Peer co-led education is included in the Norwegian national guidelines for treatment of mental disorders, but despite some promising results for the treatment of other conditions, still little is known about the efficacy of peer co-led educational group interventions interventions for adults with attention deficit and hyperactivity disorder (ADHD).

This pilot trial will evaluate patient satisfaction with and preliminary efficacy of a 2-session peer co-led educational group program designed to address specific challenges faced by adults diagnosed with ADHD at an outpatient clinics in mid-Norway.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: March 15, 2020
• Est. primary completion date: March 15, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 67 Years

Eligibility

Inclusion Criteria:

• Confirmed ADHD-diagnosis

• speaking a Scandinavian language

Exclusion Criteria:

• Unable to give informed consent

• Psychosis

• Severe learning difficulties

Related Conditions & MeSH terms

• Attention Deficit Disorder With Hyperactivity
• Hyperkinesis

Intervention

Behavioral:
• Group-based education
The group-based educational program consists of two sessions that run over two consecutive weeks. Each session consists of a lecture from a recruited expert on the topic of the session and by expert patients with a following discussion of the topic facilitated by the course leader.
• Waiting list
No educational intervention for the duration of the 10 weeks. During this period participants can receive standard treatment.

Other:
• Standard treatment
Diagnostic treatment with medication. In addition, some patients receive cognitive behavioral therapy (not systematically given to every patient). If needed, patients are also offered assistance with regard to economy, housing, education, and work as well as contact with family and network.

Locations

Country	Name	City	State
Norway	Tiller DPS	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology	St. Olavs Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Use of health services and work participation	Self-reported work participation and received services: 3 questions about both work status and received treatment	through study completion, an average of 24 weeks
Primary	Change in client Satisfaction	Client satisfaction will be measured with Client Satisfaction Questionnaire, short form (Attkisson & Zwick, 1982). The scale consists of 8 items scored on a Likert scale from 1 (low satisfaction) to 4 (high satisfaction). Total scores range from 8 to 32, with higher scores indicating greater satisfaction.	from baseline to 2-weeks follow-up
Primary	change in patient activation	Patient activation will be measured with the Norwegian version of the Patient Activation Measure Mental Health (PAM-MH) (Green et al 2010))	from baseline to 10-weeks follow-up
Secondary	change in general self-efficacy	General Self-Efficacy Scale, 6-item scale ranging from 1 ('not at all true') to 4 ('exactly true'). Total scores range from 6 to 24, with higher scores indicating greater self-efficacy. (Romppel et al 2013)	from baseline to 10 weeks follow-up
Secondary	change in ADHD-related symptoms	Hopkin's Symptom Checklist (SCL), 9-items scale with high scores on SCL-9 indicating ADHD-related symptom burden (Eich et al 2011)	from baseline to 10 weeks follow-up
Secondary	change in ADHD-related symptoms	Norwegian version of the WHO Adult ADHD Self-report scale, ASRS Short Form (Kessler et al 2005)	from baseline to 10 weeks follow-up
Secondary	change in Quality of Life	Adult Attention Deficit/Hyperactivity Disorder Quality of Life Scale, AAQoL short Form (Brod et al 2006)	from baseline to 10 weeks follow-up